Literature DB >> 21289441

Guanidination of notexin alters its membrane-damaging activity in response to sphingomyelin and cholesterol.

Pei-Hsiu Kao1, Yi-Ling Chiou, Shinne-Ren Lin, Long-Sen Chang.   

Abstract

To elucidate the contribution of phospholipase A 2 (PLA2) activity of notexin to its ability to perturb membranes, comparative studies on the interaction of notexin and guanidinated notexin (Gu-notexin) with egg yolk phosphatidylcholine (EYPC), EYPC/egg yolk sphingomyelin (EYSM) and EYPC/EYSM/cholesterol vesicles were conducted. EYSM notably reduced the membrane-damaging activity of notexin against EYPC vesicles, but had an insignificant influence on that of Gu-notexin. Unlike the effects noted with notexin, inactivation of PLA 2 activity by EDTA led to a reduction in the ability of Gu-notexin to induce EYPC/EYSM vesicle leakage and to increase Gu-notexin-induced membrane permeability of EYPC/EYSM/cholesterol vesicles. The geometrical arrangement of notexin and Gu-notexin in contact with either EYPC/EYSM vesicles or EYPC/EYSM/cholesterol vesicles differed. Moreover, global conformation of notexin and Gu-notexin differed in either Ca2+-bound or metal-free states. These results indicate that notexin and Gu-notexin could induce membrane permeability without the involvement of PLA 2 activity, and suggest that guanidination alters the membrane-bound mode of notexin on damaging phospholipid vesicles containing sphingomyelin and cholesterol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21289441     DOI: 10.1007/s12038-010-0067-6

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  30 in total

1.  The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation.

Authors:  X Xu; E London
Journal:  Biochemistry       Date:  2000-02-08       Impact factor: 3.162

2.  Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins.

Authors:  Kara S Giddings; Arthur E Johnson; Rodney K Tweten
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

Review 3.  Distribution analysis of depth-dependent fluorescence quenching in membranes: a practical guide.

Authors:  A S Ladokhin
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Notexin causes greater myotoxic damage and slower functional repair in mouse skeletal muscles than bupivacaine.

Authors:  David R Plant; Fiona E Colarossi; Gordon S Lynch
Journal:  Muscle Nerve       Date:  2006-11       Impact factor: 3.217

5.  Presynaptic snake beta-neurotoxins produce tetanic fade and endplate potential run-down during neuromuscular blockade in mouse diaphragm.

Authors:  H I Wilson; G M Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-11       Impact factor: 3.000

6.  Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2.

Authors:  K S Koumanov; P J Quinn; G Béréziat; C Wolf
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

7.  Differential binding to phospholipid bilayers modulates membrane-damaging activity of Naja naja atra cardiotoxins.

Authors:  Pei-Hsiu Kao; Shinne-Ren Lin; Long-Sen Chang
Journal:  Toxicon       Date:  2009-05-18       Impact factor: 3.033

8.  Molecular determinants of sphingomyelin specificity of a eukaryotic pore-forming toxin.

Authors:  Biserka Bakrac; Ion Gutiérrez-Aguirre; Zdravko Podlesek; Andreas F-P Sonnen; Robert J C Gilbert; Peter Macek; Jeremy H Lakey; Gregor Anderluh
Journal:  J Biol Chem       Date:  2008-04-28       Impact factor: 5.157

9.  Effects of lipid phase transition and membrane surface charge on the interfacial activation of phospholipase A2.

Authors:  Supriyo Ray; Jennifer L Scott; Suren A Tatulian
Journal:  Biochemistry       Date:  2007-10-18       Impact factor: 3.162

10.  Conformational changes that effect oligomerization and initiate pore formation are triggered throughout perfringolysin O upon binding to cholesterol.

Authors:  Alejandro P Heuck; Christos G Savva; Andreas Holzenburg; Arthur E Johnson
Journal:  J Biol Chem       Date:  2007-06-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.